PRENOSIS ANNOUNCES FDA DE NOVO MARKETING AUTHORIZATION OF THE SEPSIS IMMUNOSCORE™, ITS REVOLUTIONARY ARTIFICIAL INTELLIGENCE DIAGNOSTIC AND PREDICTIVE TOOL FOR EARLY SEPSIS DETECTION

The Sepsis ImmunoScore™ is the first-ever AI Sepsis Diagnostic granted marketing authorization by the FDA. CHICAGO, April 3, 2024 /PRNewswire/ — Prenosis, Inc., an artificial intelligence company enabling precision medicine in acute care, today announced the U.S. Food and Drug…